| 1.17 Delayed Data As of Oct 14 |  -0.03 / -2.50%Today’s Change | 1.15 Today|||52-Week Range 7.57 | -58.51% Year-to-Date |
| MedMen Shares Are Falling Again: Is the Stock Cheap Enough to Buy? 7:00am / MotleyFool.com - Paid Partner Content | 3 Cannabis Stocks That May Not Be Profitable Until 2022 Oct 12 / MotleyFool.com - Paid Partner Content |
| The Marijuana Megadeal That Wasn't: What's Next for MedMen? 6:00am / MotleyFool.com - Paid Partner Content | Marijuana Value Traps Do Exist: Here Are 3 to Avoid Oct 05 / MotleyFool.com - Paid Partner Content |
| MedMen Scraps Its PharmaCann Acquisition: Disaster or No Big Deal? Oct 14 / MotleyFool.com - Paid Partner Content | 3 Pot Stocks to Avoid Like the Plague in the Fourth Quarter Oct 02 / MotleyFool.com - Paid Partner Content |
| Wow! This Marijuana Megamerger Just Imploded. Oct 14 / MotleyFool.com - Paid Partner Content | Better Cannabis Stock: MariMed vs. Innovative Industrial Properties Sep 28 / MotleyFool.com - Paid Partner Content |
| Cannabis Stocks MedMen Enterprises and PharmaCann Scrap $682 Million Merger Oct 13 / MotleyFool.com - Paid Partner Content |
| Previous close | 1.20 |
| Today’s open | 1.25 |
| Day’s range | 1.16 - 1.27 |
| Volume | 710,799 |
| Average volume (3 months) | 917,120 |
| Market cap | $611.8M |
| Earnings growth (last year) | -675.14% |
| Earnings growth (this year) | +57.14% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +2,067,803.02% |
| P/E ratio | -- |
| Price/Sales | 0.97 |
| Price/Book | 0.50 |
| No competitors data available. |
| Next reporting date | October 29, 2019 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $39.8M |
| Annual profit (last year) | -$66.6M |
| Net profit margin | -167.53% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Culver City, California |
